Literature DB >> 26399431

Acute rhabdomyolysis associated with levetiracetam therapy in a child.

Faruk Incecik1,2, Ozlem M Herguner3, Seyda Besen3, Sakir Altunbasak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26399431     DOI： 10.1007/s13760-015-0542-9

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  5 in total

1.  Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent.

Authors:  Nagehan Aslan; Dincer Yildizdas; Behruz Huseyınlı; Ozden Ozgur Horoz; Gulen Gul Mert; Faruk Ekinci; Duygu Ozcanyuz
Journal:  J Pediatr Intensive Care       Date:  2020-01-14

2.  Population-Based Study of Risk of AKI with Levetiracetam.

Authors:  Kevin Yau; Jorge G Burneo; Racquel Jandoc; Eric McArthur; Flory Tsobo Muanda; Chirag R Parikh; Ron Wald; Matthew A Weir; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-11       Impact factor: 8.237

3.  Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?

Authors:  Antonio Siniscalchi; Scott Mintzer; Giovambattista De Sarro; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2021-11-03

4.  Effect of Levetiracetam Usage on Serum Creatine Phosphokinase Concentration in Patients with Epilepsy.

Authors:  Faruk Incecik; Ozlem M Herguner; Seyda Besen
Journal:  J Pediatr Neurosci       Date:  2020-06-27

5.  Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam.

Authors:  Vaibhav Rastogi; Devina Singh; Babbaljeet Kaur; Pulkit Arora; Jaya P Gadikota
Journal:  Cureus       Date:  2018-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.